Your browser doesn't support javascript.
loading
TGF-ß engineered mesenchymal stem cells (TGF-ß/MSCs) for treatment of Type 1 diabetes (T1D) mice model.
Daneshmandi, Saeed; Karimi, Mohammad Hossein; Pourfathollah, Ali Akbar.
Affiliation
  • Daneshmandi S; Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Karimi MH; Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: Karimimh@sums.ac.ir.
  • Pourfathollah AA; Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Int Immunopharmacol ; 44: 191-196, 2017 Mar.
Article in En | MEDLINE | ID: mdl-28110219
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transforming Growth Factor beta / Mesenchymal Stem Cell Transplantation / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 1 / Mesenchymal Stem Cells Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Int Immunopharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Year: 2017 Document type: Article Affiliation country: Iran Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transforming Growth Factor beta / Mesenchymal Stem Cell Transplantation / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 1 / Mesenchymal Stem Cells Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Int Immunopharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Year: 2017 Document type: Article Affiliation country: Iran Country of publication: Netherlands